Previous 10 | Next 10 |
Outset Medical (NASDAQ:OM) stock plunged as much as 31.5% to touch a life-low of $13.25 on Tuesday, a day after the dialysis company halted shipments of its Tablo Hemodialysis System for use at home, prompting it to suspend its prior guidance for 2022. The company after hours o...
Outset Medical (NASDAQ: OM) seemed to be at an important inflection point in the home dialysis market. The company shipped a record number of its Tablo systems for home patients in the first quarter of 2022. That momentum just hit a major bump in the road, though. Outset announc...
Gainers: Revlon (REV) +98%. biote (BTMD) +61%. Cepton (CPTN) +40%. Alpha Teknova (TKNO) +23%. New Oriental Education & Technology (EDU) +23%. Owlet (OWLT) +21%. Belite Bio (BLTE) +21%. Kaival Brands Innovations Group (KAVL) +20%. iQIYI (IQ) +17%. NIO (NIO) +16%. Redbox Entertainment (RDBX...
Gainers: Gelesis (GLS) +14%. Entrada Therapeutics (TRDA) +10%. Rhythm Pharmaceuticals (RYTM) +9%. Vivos Therapeutics (VVOS) +7%. Genfit (GNFT) +6%. Losers: Outset Medical (OM) -31%. Arcellx (ACLX) -17%. Neptune Wellness Solutions NEPT -12%. H...
Outset Medical (NASDAQ:OM) stock sank ~26% postmarket on Monday after the medical device maker halted shipments of its Tablo Hemodialysis System for home use. Shipments are halted pending the FDA's review and clearance of a 510(k) OM submitted for changes made since the device's original clea...
Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “company”) today announced it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pen...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two upcoming investor confer...
Discussion to focus on Tablo® Hemodialysis System and Home Dialysis Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it ...
The following slide deck was published by Outset Medical, Inc. in conjunction with this event. For further details see: Outset Medical (OM) Investor Presentation - Slideshow
Gainers: AxoGen (AXGN) +26%. Better Therapeutics (BTTX) +15%. Intercept Pharmaceuticals (ICPT) +13%. XORTX Therapeutics (XRTX) +13%. Belite Bio (BLTE) +8%. Losers: Nephros (NEPH) -32%. BioAtla (BCAB) -27%. Outset Medical (OM) -10%. ...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...